Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application By Watertime - August 12, 2026 4 Post Content RELATED ARTICLESMORE FROM AUTHOR Davis, Farchione and Colleagues Present FDA’s Psychedelic Drug Framework in NEJM Psychedelic Philanthropy Is Entering Its Next Phase Two New Zealand Psychiatrists Approved to Prescribe MDMA for PTSD
